Abstract
Background Atrial fibrillation (AF) may be linked to cognitive impairment in heart failure (HF) patients. Regular exercise training has numerous benefits, including improving adults’ overall health and cognitive function. However, the effects of exercise training on cognitive function in heart failure patients with reduced ejection fraction and permanent atrial fibrillation (HFAF) are not well understood.
Objective To test the hypothesis that exercise training improves cognitive function and neurovascular control in patients with HFAF.
Methods This randomized clinical trial included patients with HFAF, LVEF ≤40%, and resting HR ≤80 bpm. Montreal Cognitive Assessment score (MoCA), muscle sympathetic nerve activity (MSNA), and forearm blood flow (FBF) assessment were performed before and after the 12-week protocol period.
Results Twenty-six patients were randomized to exercise training (HFAF-trained, n=13) or no training (HFAF-untrained, n=13). At baseline, no differences between groups were found. Exercise significantly improved the MoCA score from 14.85 to 22.62 (P<0.0001), as well as those measuring processing visuospatial, memory, and attention function from 2.23 to 3.31 (P=0.02); from 1.92 to 2.69 (P=0.01); and from 2.62 to 3.85 (P=0.002), respectively. HFAF-training significantly decreased MSNA from 49.6±9.5 to 32.0±7.2 burst/min (P<0.0001) and forearm vascular resistance from 48.8±13.1 to 28.1±7 units (P<0.0001). Concomitantly, FBF increased from 1.9±0.5 to 3.0±0.7 mL/min/100mL (P<0.0001). The untrained group increased MSNA from 50.9±10.6 to 57.6±9.2 burst/min (P=0.004). No significant changes were found in the other variables in untrained patients.
Conclusion Exercise training improves cognitive function and neurovascular control in patients with heart failure with reduced ejection fraction and permanent atrial fibrillation.
Competing Interest Statement
The authors have declared no competing interest.
Clinical Trial
NCT03550872
Funding Statement
Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP # 2013/17031-6) Conselho Nacional de Desenvolvimento Cientifico e Tecnológico (CNPq # 301957/2017-7)
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethics Committee of the Heart Institute - Clinical Hospital, Medical School University of Sao Paulo
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
The data presented in this study are available on request from the 415 corresponding author.
